The prevalence of EML4-ALK variants in patients with non-small-cell lung cancer: a systematic review and meta-analysis.

Conclusion: This present study provides the exact prevalence of EML4-ALK rearrangement in different variants for NSCLC patients with ALK positive. PMID: 31432686 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research